Xiasangju alleviate metabolic syndrome by enhancing noradrenaline biosynthesis and activating brown adipose tissue

Metabolic syndrome (MetS) is a clinical condition associated with multiple metabolic risk factors leading to type 2 diabetes mellitus and other metabolic diseases. Recent evidence suggests that modulating adipose tissue to adaptive thermogenesis may offer therapeutic potential for MetS. Xiasangju (X...

Full description

Bibliographic Details
Main Authors: Changhao He, Yongcheng An, Lu Shi, Yan Huang, Huilin Zhang, Wanxin Fu, Menglu Wang, Ziyi Shan, Yuhang Du, Jiamei Xie, Zhiyun Huang, Weiguang Sun, Yonghua Zhao, Baosheng Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1371929/full